Here is a list of research and studies on CBD and it’s potential use for treating Digestive Issues.

Colitis and Crohn’s:

• Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis.
• Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis.
• The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.
• Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice.
• Cannabinoids and the gut: new developments and emerging concepts.
• Endocannabinoids and the gastrointestinal tract.
• Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review.
• Cannabis finds its way into treatment of Crohn’s disease.
• Cannabidiol in inflammatory bowel diseases: a brief overview.

Irritable Bowel Syndrome:

• Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis.
• Therapeutic potential of cannabinoid-based drugs.
• Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
• Cannabinoids and the gut: new developments and emerging concepts.
• Endocannabinoids and the gastrointestinal tract.
• Cannabinoids and gastrointestinal motility: animal and human studies.
• The Role of the Endocannabinoid System in the Brain-Gut Axis.

IMPORTANT: Most of these studies involve cannabinoid molecules, experimental animals, test tubes, and sometimes human cell-lined studies. It’s important to understand that the Endocannabinoid System exists in all mammals including dogs, cats, rabbits, horses, and humans. CBD affects us in the same way that it affects our pets.